
Analysts Viewpoint
JMP Securities analysts initates a Mkt outperform rating for Werewolf Therapeutics Inc (HOWL)
Werewolf Therapeutics Inc’s recently made public that its Director RA CAPITAL MANAGEMENT, L.P. acquired Company’s shares for reported $0.28 million